Roots Analysis is pleased to announce the publication of its recent study, titled, “Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2021-2030.”
The report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials. In addition to other elements, the study includes:
- A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures.
- A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014).
- An analysis of various developments / recent trends related to elastomeric packaging materials.
- Elaborate profiles of key players in this domain (shortlisted on the basis of size of product portfolio).
- A case study on the role of robotics in pharmaceutical manufacturing and fill / finish operations.
- An elaborate discussion on emerging trends that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry.
- An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Request for Customized Report@ Elastomeric Closures Market Size and Share
Type of packaging container
- Vials
- Syringes
- Cartridges
Type of packaging closure
- Seal
- Stopper
- Cap
- Plunger
- Barrel
- Needle Shield
Sterilization status
- Pre-sterilized
- Unsterilized
Key geographical regions
- North America
- Europe
- Asia Pacific
- Rest of the World
Key companies covered in the report
- Aptar Pharma
- Daikyo Seiko
- Datwyler Group
- DWK Life Sciences
- Hebei First Rubber Medical Technology (a Part of DESHENG Group)
- Jiangsu Hualan New Pharmaceutical Material
- Lonstroff (a Part of Sumitomo Rubber Industries)
- Ompi (a Part of Stevanato Group)
- West Pharmaceutical Services
Ask for PDF Sample:
https://www.rootsanalysis.com/reports/255/request-sample.html
Chapter Outlines
Chapter 2 provides an executive summary of the insights captured during our research. It offers a high-level view on the current state of the market of elastomeric closures and its likely evolution in the short-mid term and long term.
Chapter 3 provides an overview of conventional pharmaceutical packaging and the limitations associated with the currently used container-closure systems. The chapter also lays emphasis on innovation in the pharmaceutical packaging industry and the consequent growth of flexible fill / finish solutions. It features an elaborate discussion on the different considerations for choosing a suitable material for fabricating container-closure systems. Further, the chapter includes a detailed discussion on elastomeric materials, highlighting their properties, and applications across various industries. In addition, it provides an overview of regulatory guidelines associated with elastomeric container-closure systems. It elaborates on the various tests that are necessary to assess and control the quality of elastomeric closures. It concludes with a brief discussion on the advantages and limitations of elastomeric closures, highlighting the growing importance of coated elastomeric materials.
Chapter 4 provides a comprehensive review of the current market landscape of nearly 100 elastomeric closures. It includes a detailed analysis of the aforementioned products based on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. It also provides details of the manufacturer companies, such as year of establishment, company size, and location of headquarters.
Chapter 5 features detailed profiles of key players (shortlisted on the basis of size of product portfolio) that are involved in fabricating and supplying elastomeric closures. Each company profile features a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of executive team), financial information (if available), detailed descriptions of proprietary elastomeric closures, recent developments and an informed future outlook.
Request for Customization @ https://www.rootsanalysis.com/reports/255/request-customization.html
Also Visit Our Latest Publication
HER2 Targeting Therapies Market
North America Telecom Power Systems Market
Erythropoietic Protoporphyria Market
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
I am an Expertise in Business Development and Marketing Management with more than 5+ years in Healthcare and Pharmaceutical Industry.